rs2075783

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000523004.1(GM2A):​c.*294A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 1,589,246 control chromosomes in the GnomAD database, including 62,073 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.23 ( 4856 hom., cov: 32)
Exomes 𝑓: 0.28 ( 57217 hom. )

Consequence

GM2A
ENST00000523004.1 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.13

Publications

15 publications found
Variant links:
Genes affected
GM2A (HGNC:4367): (ganglioside GM2 activator) This gene encodes a small glycolipid transport protein which acts as a substrate specific co-factor for the lysosomal enzyme beta-hexosaminidase A. Beta-hexosaminidase A, together with GM2 ganglioside activator, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene result in GM2-gangliosidosis type AB or the AB variant of Tay-Sachs disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2009]
GM2A Gene-Disease associations (from GenCC):
  • Tay-Sachs disease AB variant
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 5-151267219-A-C is Benign according to our data. Variant chr5-151267219-A-C is described in ClinVar as Benign. ClinVar VariationId is 1234926.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.377 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GM2ANM_000405.5 linkc.427-77A>C intron_variant Intron 3 of 3 ENST00000357164.4 NP_000396.2
GM2ANM_001167607.3 linkc.413-273A>C intron_variant Intron 3 of 3 NP_001161079.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GM2AENST00000523004.1 linkc.*294A>C 3_prime_UTR_variant Exon 2 of 2 1 ENSP00000430541.1
GM2AENST00000357164.4 linkc.427-77A>C intron_variant Intron 3 of 3 1 NM_000405.5 ENSP00000349687.3

Frequencies

GnomAD3 genomes
AF:
0.226
AC:
34317
AN:
152084
Hom.:
4849
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0584
Gnomad AMI
AF:
0.216
Gnomad AMR
AF:
0.385
Gnomad ASJ
AF:
0.328
Gnomad EAS
AF:
0.276
Gnomad SAS
AF:
0.338
Gnomad FIN
AF:
0.240
Gnomad MID
AF:
0.278
Gnomad NFE
AF:
0.271
Gnomad OTH
AF:
0.264
GnomAD4 exome
AF:
0.276
AC:
396094
AN:
1437044
Hom.:
57217
Cov.:
29
AF XY:
0.277
AC XY:
198415
AN XY:
715446
show subpopulations
African (AFR)
AF:
0.0550
AC:
1809
AN:
32914
American (AMR)
AF:
0.492
AC:
21418
AN:
43558
Ashkenazi Jewish (ASJ)
AF:
0.334
AC:
8658
AN:
25884
East Asian (EAS)
AF:
0.278
AC:
10892
AN:
39190
South Asian (SAS)
AF:
0.330
AC:
28012
AN:
84920
European-Finnish (FIN)
AF:
0.247
AC:
13024
AN:
52692
Middle Eastern (MID)
AF:
0.332
AC:
1899
AN:
5722
European-Non Finnish (NFE)
AF:
0.269
AC:
294142
AN:
1092672
Other (OTH)
AF:
0.273
AC:
16240
AN:
59492
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
15219
30439
45658
60878
76097
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9884
19768
29652
39536
49420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.226
AC:
34330
AN:
152202
Hom.:
4856
Cov.:
32
AF XY:
0.230
AC XY:
17143
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0582
AC:
2420
AN:
41550
American (AMR)
AF:
0.385
AC:
5890
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.328
AC:
1137
AN:
3470
East Asian (EAS)
AF:
0.276
AC:
1430
AN:
5174
South Asian (SAS)
AF:
0.339
AC:
1632
AN:
4818
European-Finnish (FIN)
AF:
0.240
AC:
2539
AN:
10594
Middle Eastern (MID)
AF:
0.269
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
0.271
AC:
18449
AN:
67988
Other (OTH)
AF:
0.264
AC:
557
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1303
2606
3909
5212
6515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
360
720
1080
1440
1800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.258
Hom.:
2818
Bravo
AF:
0.231
Asia WGS
AF:
0.265
AC:
919
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.7
DANN
Benign
0.38
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2075783; hg19: chr5-150646780; COSMIC: COSV64095441; COSMIC: COSV64095441; API